Prodrug Nanotherapy Demonstrate In Vivo Anticryptosporidial Efficacy in a Mouse Model of Chronic Cryptosporidium Infection

Amalendu P. Ranjan; Daniel J. Czyzyk; Griselle Martinez-Traverso; Aygül Sadıqova; Margarita Valhondo; Deborah A. Schaefer; Krasimir A. Spasov; William L. Jorgensen; Jamboor K. Vishwanatha; Michael W. Riggs; Alejandro Castellanos-González; Karen S. Anderson

doi:10.1039/d4pm00093e

Prodrug Nanotherapy Demonstrate In Vivo Anticryptosporidial Efficacy in a Mouse Model of Chronic Cryptosporidium Infection

RSC Pharmaceutics

Article 2024 English

Related publications

Article2015

A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium

Anindita Mukerjee, Pinar Iyidogan, Alejandro Castellanos-González, José A. Cisneros, Daniel J. Czyzyk, Amalendu P. Ranjan, William L. Jorgensen, A. Clinton White, Jamboor K. Vishwanatha, Karen S. Anderson

Bioorganic & Medicinal Chemistry Letters

Article1995

In vivo Antiretroviral Efficacy of Oral bis(POM)-PMEA, the bis(Pivaloyloxymethyl)prodrug of 9-(2-Phosphonylmethoxyethyl) adenine (PMEA)

Lieve Naesens, Johan Neyts, Jan Balzarini, N. Bischofberger, De Clercq Erik

Article1998

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Miguel A. Pappolla, Yau‐Jan Chyan, Rosmarıa Omar, Karen Hsiao, George Perry, Mark A. Smith, Peter Bozner

Letter2018

Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection

Shalley N. Kudalkar, Jagadish Beloor, Elias Quijano, Krasimir A. Spasov, Won‐Gil Lee, José A. Cisneros, W. Mark Saltzman, Priti Kumar, William L. Jorgensen, Karen S. Anderson

Proceedings of the National Academy of Sciences

Article2017

Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum

Maria A. DeCicco RePass, Ying Chen, Yinan Lin, Wenda Zhou, David Kaplan, Honorine Ward

Prodrug Nanotherapy Demonstrate In Vivo Anticryptosporidial Efficacy in a Mouse Model of Chronic Cryptosporidium Infection

Abstract

Discussion(0)

Related publications

A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium

In vivo Antiretroviral Efficacy of Oral bis(POM)-PMEA, the bis(Pivaloyloxymethyl)prodrug of 9-(2-Phosphonylmethoxyethyl) adenine (PMEA)

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection

Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum